Early Phase Research - Autoimmune
Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence
|
FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients
false
Early Phase Research - Autoimmune